human fibrinogen lyophilized

Italy

Drugs containing this active substance

  • RIASTAP

    It is used to treat bleeding in patients suffering from a congenital fibrinogen deficiency (hypo- or afibrinogenemia) that causes a tendency to bleed.

    Form: powder for solution for injection/infusion

    Active substance Dosage
    human fibrinogen lyophilized -

    ATC: B02BB01

    Manufacturer: CSL BEHRING GMBH